187 related articles for article (PubMed ID: 36310151)
21. Nicotinamide Mononucleotide Prevents Retinal Dysfunction in a Mouse Model of Retinal Ischemia/Reperfusion Injury.
Lee D; Tomita Y; Miwa Y; Shinojima A; Ban N; Yamaguchi S; Nishioka K; Negishi K; Yoshino J; Kurihara T
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232528
[TBL] [Abstract][Full Text] [Related]
22. The kynurenine pathway in brain tumor pathogenesis.
Adams S; Braidy N; Bessede A; Brew BJ; Grant R; Teo C; Guillemin GJ
Cancer Res; 2012 Nov; 72(22):5649-57. PubMed ID: 23144293
[TBL] [Abstract][Full Text] [Related]
23. Dynamic changes in metabolites of the kynurenine pathway in Alzheimer's disease, Parkinson's disease, and Huntington's disease: A systematic Review and meta-analysis.
Fathi M; Vakili K; Yaghoobpoor S; Tavasol A; Jazi K; Hajibeygi R; Shool S; Sodeifian F; Klegeris A; McElhinney A; Tavirani MR; Sayehmiri F
Front Immunol; 2022; 13():997240. PubMed ID: 36263032
[TBL] [Abstract][Full Text] [Related]
24. Hepatic NAD(+) deficiency as a therapeutic target for non-alcoholic fatty liver disease in ageing.
Zhou CC; Yang X; Hua X; Liu J; Fan MB; Li GQ; Song J; Xu TY; Li ZY; Guan YF; Wang P; Miao CY
Br J Pharmacol; 2016 Aug; 173(15):2352-68. PubMed ID: 27174364
[TBL] [Abstract][Full Text] [Related]
25. Activation of YAP attenuates hepatic damage and fibrosis in liver ischemia-reperfusion injury.
Liu Y; Lu T; Zhang C; Xu J; Xue Z; Busuttil RW; Xu N; Xia Q; Kupiec-Weglinski JW; Ji H
J Hepatol; 2019 Oct; 71(4):719-730. PubMed ID: 31201834
[TBL] [Abstract][Full Text] [Related]
26. Nicotinamide mononucleotide inhibits post-ischemic NAD(+) degradation and dramatically ameliorates brain damage following global cerebral ischemia.
Park JH; Long A; Owens K; Kristian T
Neurobiol Dis; 2016 Nov; 95():102-10. PubMed ID: 27425894
[TBL] [Abstract][Full Text] [Related]
27. Tryptophan metabolism through the kynurenine pathway in rat brain and liver slices.
Dale WE; Dang Y; Brown OR
Free Radic Biol Med; 2000 Jul; 29(2):191-8. PubMed ID: 10980407
[TBL] [Abstract][Full Text] [Related]
28. Characterisation of the kynurenine pathway in skin-derived fibroblasts and keratinocytes.
Sheipouri D; Grant R; Bustamante S; Lovejoy D; Guillemin GJ; Braidy N
J Cell Biochem; 2015 Jun; 116(6):903-22. PubMed ID: 25639585
[TBL] [Abstract][Full Text] [Related]
29. Uridine monophosphate synthetase enables eukaryotic
McReynolds MR; Wang W; Holleran LM; Hanna-Rose W
J Biol Chem; 2017 Jul; 292(27):11147-11153. PubMed ID: 28559281
[TBL] [Abstract][Full Text] [Related]
30. The Role of Kynurenine Pathway and NAD
Dehhaghi M; Panahi HKS; Kavyani B; Heng B; Tan V; Braidy N; Guillemin GJ
Aging Dis; 2022 Jun; 13(3):698-711. PubMed ID: 35656104
[TBL] [Abstract][Full Text] [Related]
31. Assessment of Prenatal Kynurenine Metabolism Using Tissue Slices: Focus on the Neosynthesis of Kynurenic Acid in Mice.
Notarangelo FM; Beggiato S; Schwarcz R
Dev Neurosci; 2019; 41(1-2):102-111. PubMed ID: 31117076
[TBL] [Abstract][Full Text] [Related]
32. Exogenous nicotinamide adenine dinucleotide administration alleviates ischemia/reperfusion-induced oxidative injury in isolated rat hearts via Sirt5-SDH-succinate pathway.
Liu L; Wang Q; Zhao B; Wu Q; Wang P
Eur J Pharmacol; 2019 Sep; 858():172520. PubMed ID: 31278893
[TBL] [Abstract][Full Text] [Related]
33. Activation of the kynurenine pathway and increased production of the excitotoxin quinolinic acid following traumatic brain injury in humans.
Yan EB; Frugier T; Lim CK; Heng B; Sundaram G; Tan M; Rosenfeld JV; Walker DW; Guillemin GJ; Morganti-Kossmann MC
J Neuroinflammation; 2015 May; 12():110. PubMed ID: 26025142
[TBL] [Abstract][Full Text] [Related]
34. NAD
Groth B; Venkatakrishnan P; Lin SJ
Front Mol Biosci; 2021; 8():686412. PubMed ID: 34095234
[TBL] [Abstract][Full Text] [Related]
35. Nicotinamide adenine dinucleotide metabolism as an attractive target for drug discovery.
Khan JA; Forouhar F; Tao X; Tong L
Expert Opin Ther Targets; 2007 May; 11(5):695-705. PubMed ID: 17465726
[TBL] [Abstract][Full Text] [Related]
36. Secretion of quinolinic acid, an intermediate in the kynurenine pathway, for utilization in NAD+ biosynthesis in the yeast Saccharomyces cerevisiae.
Ohashi K; Kawai S; Murata K
Eukaryot Cell; 2013 May; 12(5):648-53. PubMed ID: 23457190
[TBL] [Abstract][Full Text] [Related]
37. Role of d-amino acid oxidase in the production of kynurenine pathway metabolites from d-tryptophan in mice.
Notarangelo FM; Wang XD; Horning KJ; Schwarcz R
J Neurochem; 2016 Feb; 136(4):804-814. PubMed ID: 26661897
[TBL] [Abstract][Full Text] [Related]
38. Recent advances in clinical trials targeting the kynurenine pathway.
Pires AS; Sundaram G; Heng B; Krishnamurthy S; Brew BJ; Guillemin GJ
Pharmacol Ther; 2022 Aug; 236():108055. PubMed ID: 34929198
[TBL] [Abstract][Full Text] [Related]
39. The metabolites of
Wang Y; Guan Y; Xie Q; Gong W; Li J; Chen T; Xu Y; Xu N; Chen S; Chen M; Wang Z; Hao CM
Clin Kidney J; 2023 Apr; 16(4):711-721. PubMed ID: 37007695
[TBL] [Abstract][Full Text] [Related]
40. Resistin and visfatin in steatotic and non-steatotic livers in the setting of partial hepatectomy under ischemia-reperfusion.
Elias-Miró M; Mendes-Braz M; Cereijo R; Villarroya F; Jiménez-Castro MB; Gracia-Sancho J; Guixé-Muntet S; Massip-Salcedo M; Domingo JC; Bermudo R; Rodés J; Peralta C
J Hepatol; 2014 Jan; 60(1):87-95. PubMed ID: 23968888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
